Source: OncLive, March 2019 Hussein A. Tawbi, MD, PhD, associate professor, The University of Texas MD Anderson Cancer Center, discusses unmet needs in melanoma. There are many unmet needs in melanoma, one of which includes improving the cure rate with the least toxicity. Combination therapies are often used over the course of a patient’s treatment […]
Archive | Video Reports
Dr. Triebel on the Rationale for a Novel Immunotherapy Combination in Melanoma
Source: OnClive, February 2019 Frederic Triebel, MD, PhD, chief scientific officer and chief medical director, Immutep Ltd, discusses the rationale for a novel immunotherapy combination in patients with unresectable or metastatic melanoma. An ongoing study is looking at combining PD-1 inhibition, specifically pembrolizumab (Keytruda), with antigen-presenting cells in an attempt to block 2 checkpoints concurrently. […]
Posted in Melanoma News, Health Professionals, Video Reports
Emerging Combination Therapies in Advanced Melanoma
Source: OncLive, February 2019 Transcript: Axel Hauschild, MD: We are already touching on the field of emerging strategies. There was some news this year from other conferences, as well as an abstract on anti–LAG-3 [lymphocyte-activation gene 3] as a second-line treatment option in patients who were progressive on PD-1 [programmed cell death protein 1] antibodies. Here, […]
Posted in Melanoma News, Health Professionals, Video Reports
Future Outlook: Treating Advanced Melanoma
Source: OncLive, February 2019 Transcript: Axel Hauschild, MD: At the end of our discussion, I want to touch on 2 new components with different modes of action. There is the NKTR component, which is called NKTR-214. There was a trial released at ASCO [American Society of Clinical Oncology Annual Meeting] on this. Merrick, are you familiar […]
Posted in Melanoma News, Health Professionals, Video Reports
